Continuous Transcatheter Arterial Thrombolysis for Early Hepatic Artery Thrombosis After Liver Transplantation
Autor: | Jianping Fan, Yi Wang, Zhi-Quan Wu, Zhi Chao Wang, Yuxin Shi, Jian-Hua Wang, Yue-Fang Shen, X.-W. Huang, Zhao-You Tang, Shuang-Jian Qiu, Jian Zhou |
---|---|
Rok vydání: | 2005 |
Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Liver transplantation Revascularization Catheterization Hepatic Artery Fibrinolytic Agents parasitic diseases Fibrinolysis medicine Humans Thrombolytic Therapy Retrospective Studies Urokinase Transplantation medicine.diagnostic_test business.industry Angiography Thrombosis Thrombolysis Middle Aged Urokinase-Type Plasminogen Activator Liver Transplantation Surgery medicine.anatomical_structure business medicine.drug Artery |
Zdroj: | Transplantation Proceedings. 37:4426-4429 |
ISSN: | 0041-1345 |
DOI: | 10.1016/j.transproceed.2005.10.113 |
Popis: | Early hepatic artery thrombosis (HAT) after orthotopic liver transplantation remains a significant cause of graft loss and patient death. The most effective treatment approach is still controversial. The purpose of this study was to assess the effect of continuous transcatheter arterial thrombolysis in the treatment of early HAT. Routine posttransplant color Doppler imaging (CDI) was performed to monitor hepatic artery blood flow. HAT was confirmed by arterial angiography in suspected cases. HAT was identified in 8 patients (8/287, 2.8%) which occurred on days 2 to 19 (mean, 5.2 days) after liver transplantation. Patients with HAT were treated with continuous transcatheter arterial thrombolysis using urokinase. Successful revascularization through thrombolysis was obtained in all eight cases. One patient died of a pulmonary infection at 2 months after liver transplantation. Another patient underwent retransplantation because of resistant allograft rejection and recurrence of HAT 6 months after the first operation, but died from multiple system organ failure 2 months later. The other six patients remained in good health during the follow-up period of 3 to 27 months. Our results demonstrate that CDI is an effective method to monitor the occurrence of early HAT after liver transplantation. Furthermore, continuous transcatheter arterial thrombolysis with urokinase could be a rational therapeutic approach to rescue the allograft following early HAT diagnosis confirmed by arterial angiography. |
Databáze: | OpenAIRE |
Externí odkaz: |